A study undertaken to determine the ovicidal efficacy of abametapir against eggs of both human head and body lice has revealed that abametaphir has an 100% ovicidal activity in vitro assessments and therefore able to inhibit hatching of both head and body louse eggs if used in specific concetrations.

TyraTech has reported an increase of 31% in sales during the first half of 2016.

The head lice brand Hedrin has announced the launch of a Stubborn Egg Loosening Lotion and suggested that this new addition to the Hedrin family would make it easy to remove dead eggs from the hair after treatment.

New commentary warns of the risks of excessive use of ivermectin for unauthorized groups.

Hatchtech is submitting its Xeglyze lice treatment to the FDA for approval and has signed a commercialisation agreement with Dr. Reddy’s.

A summary of several smaller-impact papers on head lice published in 2015.

Two new papers on ivermectin provide evidence for synergistic anti-lice activity when combined with antibiotics.

A review of literature searches and clinical trials on Pediculosis has provided an overview on managing and treating human lice. This review highlights new strategies to more effectively fight pediculoisis and prevent resistance.

A review providing the relevant information on infestation treatments available in the United States has revealed that there is a high risk of failure of over-the-counter treatments in eliminating head lice.

A study testing a neem-extract head lice treatment has found evidence for efficacy in treating head lice infection.